Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02363166 · ClinicalTrials.gov registry record
Analysis of CA-MRSA Transmission: An ED Population Sampling Strategy
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 575
- Enrollment target
NCT02363166 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 575 participants.
The verdict
NCT02363166 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 575 participants
- Enrollment target
Study Summary
Given that the Emergency Department (ED) has become the entry way for large populations of patients into the health care system, a strategy of sampling MRSA isolates in ED populations and merging this information with patient-level data may present a window to hypothesize and investigate CA-MRSA transmission within the community and its impact on hospital-acquired infections.
Interventions
- OTHER Acute Abscess Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 575 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02363166
The ClinicalTrials.gov registry entry for NCT02363166 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 575 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acute Abscess Group is the first listed.
NCT02363166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02363166 about?
NCT02363166 is a clinical study titled "Analysis of CA-MRSA Transmission: An ED Population Sampling Strategy". Given that the Emergency Department (ED) has become the entry way for large populations of patients into the health care system, a strategy of sampling MRSA isolates in ED populations and merging this information with patient-level data may present a window to hypothesize and investigate CA-MRSA tra...
What is the current status of trial NCT02363166?
This trial is currently completed. The enrollment target is 575 participants. The study started on 2015-08. Estimated completion is 2018-04-04.
What interventions are being tested in trial NCT02363166?
The interventions under investigation include: Acute Abscess Group (OTHER).
Who is sponsoring clinical trial NCT02363166?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.